This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2011
Canada’s Pharmaceutical Products Industry: Industrial Profile Winter 2011
$565.00
- Aging Population—People spend more on pharmaceutical products as they age. Thus, with the average age of the population increasing, so is per capita spending on drugs.
- Government Budgets—Most developed countries will move to tighten their budgets in the coming years in a bid to return to financial balance, and public health-care spending will be affected.
- Prices—Growing competition from emerging markets and generic products limits price increases.
Effective January 26, 2026, AERIC Inc./Signal49 Research discontinued use of ‘The Conference Board of Canada’ name, logo and branding, which had been used by AERIC Inc./Signal49 Research under license from The Conference Board, Inc. The Conference Board, Inc. and its licensees, which are not affiliated with Signal49 Research, own all right, title and interest in THE CONFERENCE BOARD name and trademarks in Canada and have the exclusive right to their use in Canada since January 26, 2026.
